Douglas E. Feltner
Exicure (United States)(US)
Publications by Year
Research Areas
Neurogenetic and Muscular Disorders Research, Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes, RNA modifications and cancer, Child and Adolescent Psychosocial and Emotional Development, Treatment of Major Depression
Most-Cited Works
- → Altered Brain Serotonin Homeostasis and Locomotor Insensitivity to 3,4-Methylenedioxymethamphetamine (“Ecstasy”) in Serotonin Transporter-Deficient Mic(1998)710 cited
- → Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli.(1984)525 cited
- → Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial(2021)456 cited
- → Ca2+ channel α2δ ligands: novel modulators of neurotransmission(2007)384 cited
- → Vocal Acoustic Biomarkers of Depression Severity and Treatment Response(2012)318 cited
- → Pregabalin in Generalized Anxiety Disorder: A Placebo-Controlled Trial(2003)316 cited